Esomeprazole Sodium Powder Cas No.161796-78-7
Product Origin: Synthetic
Specification: ≥98.5%
CAS No.: 161796-78-7
Molecular Formula: C34H36MgN6O6S2
Molecular Weight: 713.12
Testing Method: HPLC
Active Ingredient: Esomeprazole Sodium
Product Characteristics: White or off-white to pale beige crystalline powder
Product Packaging: 1kg/bag; 25kg/drum
Storage Conditions: Store in a dry place, protected from light, and sealed
Shelf Life: 24 months
Declaration of Use: This product is intended for industrial use or scientific research only.
Products Description
High-Purity Esomeprazole Sodium API | CAS 161796-78-7
Esomeprazole Sodium (CAS No. 161796-78-7) is the highly soluble sodium salt of the S-enantiomer of omeprazole. As a highly potent and specific Proton Pump Inhibitor (PPI), it is fundamentally superior to racemic omeprazole due to its targeted metabolic profile and enhanced systemic bioavailability. Manufactured under strict cGMP protocols, Xi'an Tihealth provides pharmaceutical-grade Esomeprazole Sodium engineered specifically for sterile formulation. Characterized by excellent aqueous solubility and strictly controlled bacterial endotoxins, our API is the gold-standard starting material for compounding intravenous (IV) lyophilized powders and advanced gastric acid suppression therapeutics.
Technical Data Sheet (TDS) & Core Specifications
To meet the uncompromising safety and stability standards required for intravenous administration, our API undergoes exhaustive analytical profiling:
| Testing Item | Specification (API Standard) |
|---|---|
| Chemical Name | Sodium (S)-5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| Assay (HPLC, Anhydrous) | ≥ 99.0% |
| Enantiomeric Purity | ≥ 99.5% (Strict S-isomer retention; minimal R-isomer) |
| Appearance | White to slightly colored crystalline powder |
| Bacterial Endotoxins | Strictly controlled (Suitable for Injection-Grade compounding) |
| Solubility | Freely soluble in water and ethanol |
Pharmacological Mechanism of Action
Esomeprazole Sodium exerts highly targeted and irreversible inhibition of gastric acid secretion through a specialized cellular mechanism:
- Proton Pump Inhibition: It accumulates in the highly acidic secretory canaliculi of the gastric parietal cell. Here, it is converted into the active sulfenamide form, which covalently binds to the H+/K+-ATPase enzyme (the proton pump).
- Blockade of Acid Secretion: By irreversibly blocking this final step in the acid production pathway, it effectively suppresses both basal and stimulated gastric acid secretion, providing rapid and sustained elevation of intragastric pH.
- Metabolic Advantage: As a pure S-enantiomer, it undergoes less first-pass hepatic metabolism via the CYP2C19 enzyme compared to racemic omeprazole, resulting in higher plasma concentrations and more consistent clinical efficacy.
Pharmaceutical Formulation Applications
- Sterile Injectables (IV): The definitive API for formulating lyophilized powders for injection, utilized in acute clinical settings where oral administration is not feasible (e.g., bleeding peptic ulcers, severe erosive esophagitis).
- Advanced Solid Dosages: Also utilized in the development of specialized delayed-release or enteric-coated oral formulations due to its reliable stability profile.
Regulatory Compliance Notice: Esomeprazole Sodium is an active pharmaceutical ingredient (API) supplied strictly for B2B industrial formulation, GMP manufacturing, and laboratory R&D. It must undergo professional sterilization and compounding prior to clinical administration.
Frequently Asked Questions (FAQ)
The primary difference lies in their solubility and formulation intent. Esomeprazole Sodium is highly soluble in water, making it the required salt form for sterile intravenous (IV) injections. Conversely, Esomeprazole Magnesium exhibits lower solubility and is standardly used for formulating solid oral dosages (delayed-release tablets or capsules).
Is this API suitable for lyophilized powder formulations?
Yes. Our pharmaceutical-grade Esomeprazole Sodium API undergoes rigorous endotoxin and microbial limit testing, ensuring it is a safe and reliable starting material for producing clinical-grade lyophilized powders for injection.
What are the storage recommendations for Esomeprazole Sodium?
As a hygroscopic and light-sensitive API, it must be stored in airtight, light-resistant containers. We recommend cold storage (typically 2°C to 8°C) to maintain its chiral purity and prevent chemical degradation over its shelf life.
Hot Tags: esomeprazole sodium powder cas no.161796-78-7, China esomeprazole sodium powder cas no.161796-78-7 manufacturers, suppliers, factory, hialuronato de sodio hialuronato sodico sodium hyaluronate, , ,
You Might Also Like
Send Inquiry








